Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab Fundamental US Large Company Index ETF
FNDX
|
+$8.54B |
| 2 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$6.22B |
| 3 |
Schwab US Large- Cap ETF
SCHX
|
+$6.12B |
| 4 |
Schwab Fundamental US Small Company Index ETF
FNDA
|
+$5.39B |
| 5 |
Schwab 5-10 Year Corporate Bond ETF
SCHI
|
+$5.01B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Texas Instruments
TXN
|
+$367M |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$335M |
| 3 |
Diageo
DEO
|
+$297M |
| 4 |
Medtronic
MDT
|
+$259M |
| 5 |
GE Aerospace
GE
|
+$222M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.36% |
| 2 | Financials | 10.66% |
| 3 | Healthcare | 9.68% |
| 4 | Consumer Discretionary | 8.35% |
| 5 | Industrials | 7.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1676
Doximity
DOCS
$3.76B
| $20.2M | ﹤0.01% |
721,035
+1,794
| +0.2% | +$47.3K |
|
|
PGRE
1677
DELISTED
Paramount Group
PGRE
| $20.2M | ﹤0.01% |
4,352,611
-633,821
| -13% | -$2.94M |
|
1678
PTC Therapeutics
PTCT
$5.68B
| $20.1M | ﹤0.01% |
658,828
+39,535
| +6% | +$1.28M |
|
|
NUVL
1679
DELISTED
Nuvalent
NUVL
| $20.1M | ﹤0.01% |
265,291
+23,247
| +10% | +$1.65M |
|
1680
Expro Ltd
XPRO
$1.79B
| $20.1M | ﹤0.01% |
876,597
+125,449
| +17% | +$2.6M |
|
1681
Nelnet
NNI
$4.88B
| $20.1M | ﹤0.01% |
199,076
+4,213
| +2% | +$419K |
|
|
SWTX
1682
DELISTED
SpringWorks Therapeutics
SWTX
| $19.9M | ﹤0.01% |
528,614
+10,641
| +2% | +$448K |
|
1683
Marqeta
MQ
$1.83B
| $19.9M | ﹤0.01% |
907,024
+35,962
| +4% | +$792K |
|
1684
Huron Consulting
HURN
$2.41B
| $19.8M | ﹤0.01% |
201,454
+7,950
| +4% | +$731K |
|
1685
Open Text
OTEX
$6.15B
| $19.8M | ﹤0.01% |
+660,567
| New | +$21.2M |
|
|
BRSL
1686
Brightstar Lottery PLC
BRSL
$1.84B
| $19.8M | ﹤0.01% |
967,258
+161,802
| +20% | +$3.31M |
|
1687
Enterprise Products Partners
EPD
$82.3B
| $19.8M | ﹤0.01% |
682,515
-38,213
| -5% | -$1.1M |
|
|
PMT
1688
PennyMac Mortgage Investment
PMT
$822M
| $19.8M | ﹤0.01% |
1,438,245
+20,684
| +1% | +$290K |
|
1689
Donnelley Financial Solutions
DFIN
$1.16B
| $19.8M | ﹤0.01% |
331,672
+717
| +0.2% | +$43.8K |
|
1690
Agios Pharmaceuticals
AGIO
$1.79B
| $19.7M | ﹤0.01% |
457,527
+17,295
| +4% | +$624K |
|
1691
GFL Environmental
GFL
$14.9B
| $19.7M | ﹤0.01% |
+506,167
| New | +$17.3M |
|
1692
Vericel Corp
VCEL
$2.35B
| $19.7M | ﹤0.01% |
428,702
+2,124
| +0.5% | +$100K |
|
1693
Celldex Therapeutics
CLDX
$2.99B
| $19.6M | ﹤0.01% |
530,443
+31,222
| +6% | +$1.18M |
|
1694
Northwest Natural Holdings
NWN
$2.06B
| $19.5M | ﹤0.01% |
539,309
+30,282
| +6% | +$1.12M |
|
1695
Freshworks
FRSH
$3.14B
| $19.4M | ﹤0.01% |
1,532,214
+211,082
| +16% | +$3.16M |
|
1696
Uranium Energy
UEC
$4.75B
| $19.4M | ﹤0.01% |
3,230,398
+116,036
| +4% | +$789K |
|
|
MFA
1697
MFA Financial
MFA
$926M
| $19.4M | ﹤0.01% |
1,823,338
+54,243
| +3% | +$584K |
|
1698
Atmus Filtration Technologies
ATMU
$4.22B
| $19.4M | ﹤0.01% |
674,029
+9,908
| +1% | +$300K |
|
1699
Jack in the Box
JACK
$312M
| $19.4M | ﹤0.01% |
380,472
+31,354
| +9% | +$1.76M |
|
1700
Wolfspeed
WOLF
$1.23B
| $19.3M | ﹤0.01% |
850,048
+12,224
| +1% | +$316K |
|
Similar funds
Charles Schwab's Q2 2024 Portfolio in Review
As of Q2 2024, Charles Schwab held 3,738 positions worth $525B, up 21% from $433B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Charles Schwab deployed $84.3B of net new capital in Q2 2024, opening 263 new positions and adding to 2,391 existing holdings. Its largest new stake was Schwab Fundamental US Small Company Index ETF: 195,294,508 shares worth $5.36B.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Texas Instruments, an estimated $367M trimmed.
- Charles Schwab's largest Q2 2024 buy was Schwab Fundamental US Small Company Index ETF: 195,294,508 shares worth $5.36B.
- Charles Schwab added most to Schwab Fundamental US Large Company Index ETF in Q2 2024, an estimated $8.54B increase.
- Charles Schwab's biggest Q2 2024 reduction was Texas Instruments, cutting an estimated $367M.
- Charles Schwab fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $335M.
- Charles Schwab's ten largest holdings make up 21% of its $525B portfolio in Q2 2024.
- Charles Schwab opened 263 new positions and closed 116 in Q2 2024.
- Charles Schwab's portfolio value rose 21% quarter-over-quarter to $525B.
Based on Charles Schwab's 13F filing for Q2 2024, filed 12 Aug 2024.